Previous close | 15.45 |
Open | 15.45 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 15.45 - 15.45 |
52-week range | 14.52 - 22.64 |
Volume | |
Avg. volume | 800 |
Market cap | 14.268B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 24.52 |
EPS (TTM) | 0.63 |
Earnings date | N/A |
Forward dividend & yield | 0.38 (2.43%) |
Ex-dividend date | 31 Mar 2022 |
1y target est | N/A |
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
In this article we will quickly re-cap the broker forecasts for Smith amp;amp; Nephew (LON:SN.). The Smith amp;amp; Nephew share price has risen by 1.46% ove...
The absence of any nasty surprises, after a couple of disappointing updates in 2021, represents a good start to 2022 for Smith & Nephew and this column continues to believe that the orthopaedics, wound care and sports medicine specialist could yet be a beneficiary of anything like a return to normality in hospitals as and when the pandemic finally wanes.